The use of interleukin 1 receptor antagonist (anakinra) in Kawasaki disease: A retrospective cases seriesIsabelle Koné‐Paut, Maryam Piram, Rolando Cimaz et al.|Autoimmunity Reviews|2018Cited by 129
Missed or delayed diagnosis of Kawasaki disease during the 2019 novel coronavirus disease (COVID-19) pandemicAshraf S. Harahsheh, Jane C. Burns, Maryam Piram et al.|The Journal of Pediatrics|2020Cited by 112